Compare CAL & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAL | NPCE |
|---|---|---|
| Founded | 1878 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.3M | 432.3M |
| IPO Year | 1994 | 2021 |
| Metric | CAL | NPCE |
|---|---|---|
| Price | $11.13 | $14.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $15.00 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 717.0K | 200.5K |
| Earning Date | 03-19-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | $85,513,000.00 | ★ $99,986,000.00 |
| Revenue This Year | $3.89 | $0.90 |
| Revenue Next Year | $3.25 | $24.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.46 | ★ 25.13 |
| 52 Week Low | $8.80 | $7.56 |
| 52 Week High | $17.60 | $18.97 |
| Indicator | CAL | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 56.94 |
| Support Level | $10.33 | $14.02 |
| Resistance Level | $11.88 | $14.72 |
| Average True Range (ATR) | 0.64 | 0.67 |
| MACD | 0.15 | 0.18 |
| Stochastic Oscillator | 73.72 | 84.06 |
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.